Modelling the impact of extended vaccination strategies on the epidemiology of pertussis

Epidemiology and Infection

Volumn 140, Issue 8, 2012, Pages 1503-1514

  Rozenbaum, M H ^a   De Vries, R ^a   Le, H H ^a   Postma, M J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Infectious disease control; mathematical modelling; pertussis (whooping cough); public health; vaccine policy development

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS VACCINE;

AGE DISTRIBUTION; ARTICLE; INCIDENCE; INFECTION CONTROL; MATHEMATICAL MODEL; NETHERLANDS; PERTUSSIS; SENSITIVITY ANALYSIS; UNCERTAINTY; VACCINATION;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; MIDDLE AGED; MODELS, BIOLOGICAL; NETHERLANDS; PERTUSSIS VACCINE; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84863960567     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268811002354     Document Type: Article

References (35)

1. Celentano LP, et al. Resurgence of pertussis in Europe. Pediatric Infectious Disease Journal 2005; 24: 761-765.
2. Ntezayabo B, de Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatric Infectious Disease Journal 2003; 22: 22-27.
3. Quinn HE, McIntyre PB. Pertussis epidemiology in Australia over the decade 1995-2005 - trends by region and age group. Communicable Diseases Intelligence 2007; 31: 205-215.
4. de Melker HE, et al. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infectious Diseases 1997; 3: 175-178.
5. de Greeff SC, et al. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatric Infectious Disease Journal 2008; 27: 218-223.
6. Guris D, et al. Changing epidemiology of pertussis in the United States : increasing reported incidence among adolescents and adults, 1990-1996. Clinical Infectious Diseases 1999; 28: 1230-1237.
7. Skowronski DM, et al. The changing age and seasonal profile of pertussis in Canada. Journal of Infectious Diseases 2002; 185: 1448-1453.
8. Bisgard KM, et al. Infant pertussis : who was the source? Pediatric Infectious Disease Journal 2004; 23: 985-989.
9. Elliott E, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatric Infectious Disease Journal 2004; 23: 246-252.
10. Wendelboe AM, et al. Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 2007; 26: 293-299.
11. Halperin SA. Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents : implications for the United States. Pediatric Infectious Disease Journal 2005; 24: S141-S146.
12. Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatric Infectious Disease Journal 2005; 24: S10-S18.
13. de Greeff SC, et al. Pertussis disease burden in the household: how to protect young infants. Clinical Infectious Diseases 2010; 50: 1339-1345.
14. Coudeville L, van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States : evaluation of routine and targeted (cocoon) strategies. Epidemiology and Infection 2008; 136: 604-620.
15. van Boven M, et al. A model based evaluation of the 1996-7 pertussis epidemic in The Netherlands. Epidemiology and Infection 2001; 127: 73-85.
16. Coudeville L, et al. Adult vaccination strategies for the control of pertussis in the United States : an economic evaluation including the dynamic population effects. PLoS One 2009; 4: e6284.
17. de Vries R, et al. Cost-effectiveness of adolescent pertussis vaccination for The Netherlands: using an individual-based dynamic model. PLoS One 2010; 5: e13392.
18. Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22: 2181-2191.
19. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination : computer simulations of five new strategies. Vaccine 2004; 22: 3154-3165.
20. Wendelboe AM, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005; 24: S58-S61.
21. van Boven M, et al. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Mathematical Biosciences 2000; 164: 161-182.
22. Farrington CP. The measurement and interpretation of age-specific vaccine efficacy. International Journal of Epidemiology 1992; 21: 1014-1020.
23. Ramsay ME, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiology and Infection 1993; 111: 41-48.
24. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003; 21: 2003-2014.
25. Zhang L, et al. Acellular vaccines for preventing whooping cough in children. Cochrane Database of Systematic Reviews 2009. Issue 4. Art No.: CD001478.
26. Casey JR, Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs 2005; 65: 1367-1389.
27. Frampton JE, Keam SJ. Reduced- Antigen, combined diphtheria-tetanus- Acellular pertussis vaccine, adsorbed (Boostrix) US formulation: use as a single-dose booster immunization in adolescents aged 10-18 years. Paediatric Drugs 2006; 8: 189-195.
28. Ward JI, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. New England Journal of Medicine 2005; 353: 1555-1563.
29. de Melker HE, et al. The incidence of Bordetella pertussis infections estimated in the population from
30. De Greeff SC, et al. Pertussis in the Netherlands, 2001-2002. RIVM report 128507010/2003.
31. Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. American Journal of Epidemiology 2006; 164: 936-944.
32. Mossong J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 2008; 5: e74.
33. de Greeff SC, et al. Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003 [in Dutch]. Nederlands Tijdschrift Voor Geneeskunde 2005; 149: 937-943.
34. van Rie A, Wendelboe AM, Englund JA. Role of maternal pertussis antibodies in infants. Pediatric Infectious Disease Journal 2005; 24: S62-S65.
35. Anderson RM, May RM. Infectious Diseases of Humans. Oxford: Oxford University Press, 1991.